Corona Virus

FDA inspection report casts doubt on J&J vaccine contractor’s ability to restart production

The FDA said the size and design of Emergent’s manufacturing facilities could prevent its bid to deliver millions of doses of Covid-19 vaccines this year.Read More

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top